Pricing Log in Create free account

Abeona Therapeutics Inc. (ABEO) vs Evommune Inc. (EVMN)

Abeona Therapeutics Inc. and Evommune Inc. are both Biotechnology companies. Abeona Therapeutics Inc. and Evommune Inc. are of similar size ($241.3M and $238.5M). Evommune Inc. has the higher net margin (0.00% vs −242.6%) and the lower return on invested capital (−82.5% vs 0.00%). Across the 13 metrics below, Evommune Inc. leads on 8 and Abeona Therapeutics Inc. on 5.

Valuation

Metric ABEO EVMN Biotechnology median
P/E n/m n/m 10.60
P/S 9.18 n/m 9.40
P/B 1.86 0.87 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 4.09 n/m 9.02
Earnings yield (28.06%) (165.86%) (32.88%)
Free cash flow yield (34.27%) (31.07%) (23.13%)

Profitability

Metric ABEO EVMN Biotechnology median
Gross margin 66.03% — 68.51%
Operating margin (322.59%) 0.00% 0.00%
Net margin (242.62%) 0.00% 0.00%
Free cash flow margin (314.53%) 0.00% 0.00%
Return on equity (43.13%) (141.99%) (51.96%)
Return on assets (29.54%) (62.71%) (46.06%)
Return on invested capital 0.00% (82.46%) 0.00%

Growth

Metric ABEO EVMN Biotechnology median
Revenue growth (TTM) 427.47% — 6.76%
EPS growth (last fiscal year) 165.16% 75.23% 29.88%
Revenue growth, 5-year CAGR 14.19% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ABEO EVMN Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 6.63 11.68 4.97
Net debt to EBITDA 2.00 1.87 1.01

Dividend

Metric ABEO EVMN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABEO EVMN Biotechnology median
Market cap 238.46m 241.34m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack